Search

everythinglearnresearchcommunity

for

Search:↓

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Gender and social factors, not just biology, affect COVID-19 death rates.

Natural products might help treat COVID-19, but current drugs like hydroxychloroquine haven't worked.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

The Covishield COVID-19 vaccine caused skin-related side effects in 1.23% of the people vaccinated in the study from India.

Scalp inflammation can cause multiple hairs to grow from one follicle.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Nearly half of the studied men with long COVID had low testosterone, including younger men.

Bacterial extracellular vesicles could revolutionize regenerative medicine but need safety improvements.

Cathelicidins could treat skin issues but face challenges like safety and resistance.

Nearly 20% of recovered COVID-19 patients have skin issues, with hair loss and rashes being common.

Most COVID-19 survivors developed post-acute symptoms, especially if they had been in the ICU, but the severity of initial infection didn't predict these symptoms.

Combining traditional Chinese medicine with microneedles shows promise for effectively treating skin diseases with fewer side effects.

Iron deficiency is the main cause of hair loss in women, and iron supplements started within 6 months can improve hair health.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Scalp involvement in primary cutaneous lymphomas is common and can be aggressive, requiring careful attention.

Microneedles could revolutionize pediatric medicine by offering painless drug delivery, but more development is needed.

Extracellular vesicles show promise as treatments but need more research for safety and effectiveness.

Microneedle patches could replace injections but need more development for better use in medicine.

Biomimetic synthetic vesicles could improve precision medicine by combining natural and synthetic benefits.

Polysaccharides boost immunity and could help prevent and treat diseases.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

The intestinal lymphatic system is active and promising for targeted drug delivery and therapies.

Self-amplifying RNA could be a better option for protein replacement therapy with lower doses and lasting effects, but delivering it into cells is still challenging.

Shi-Bi-Man, a Traditional Chinese Medicine, helps grow hair by boosting lactic acid metabolism and activating hair follicle stem cells.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

COVID-19 may trigger hair loss conditions like alopecia areata.

New understanding and treatments for hair loss are improving, but more research is needed.